Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01884285
Title AZD8186 First Time In Patient Ascending Dose Study
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors AstraZeneca
Indications

triple-receptor negative breast cancer

lung non-small cell carcinoma

Advanced Solid Tumor

prostate cancer

Therapies

AZD8186

Abiraterone + AZD8186

AZD8186 + Vistusertib

Age Groups: senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST